In an efficacy study of gastric ulcer, one case of abdominal pain was reported among 81 patients who received rebamipide 900 mg/day (maximum dosage of the study). In post marketing experience, there is limited information on overdose. Treatment of overdose should be symptomatic. Close medical supervision and monitoring should continue until the patient recovering.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
